APIs and Excipients

Acasti Pharma and CordenPharma Announce Large-Scale Production of CaPre with Continuous Manufacturing

June 06, 2017

Acasti Pharma and CDMO CordenPharma designed and implemented a continuous process for purifying raw krill oil for production of omega-3 phospholipid.

Cambrex Increases API Capacity in US, Europe

June 05, 2017

PTSM: Pharmaceutical Technology Sourcing and Management

Cambrex announces expansions of its North Carolina API pilot plant and Kalskoga, Sweden large-scale manufacturing facility.

Construction Approach of a Phosgenation Laboratory and GMP Plant at Valsynthese

June 05, 2017

The author describes the construction approach of a phosgene R&D laboratory and a medium-scale commercial phosgenation plant at Valsynthese.

Accessing Cannabinoids Using Biocatalysis

June 02, 2017

Efficient synthesis of complex cannabinoids is possible while avoiding marijuana cultivation.

Spectrum Opens Pharmacy Training Center

June 02, 2017

PTSM: Pharmaceutical Technology Sourcing and Management

Spectrum Pharmacy Products opens pharmacy institute for training in pharmaceutical compounding.

BioVectra Builds Fermentation and Complex Chemistry Facility in Nova Scotia

May 30, 2017

PTSM: Pharmaceutical Technology Sourcing and Management

BioVectra will open its new microbial fermentation and complex chemistry site, including the capability to handle high-potency APIs, by the end of 2017.

In implementing quality by design for drug formulation, it is crucial to identify the critical properties of excipients and understand how their variation affects the final drug product.